---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-003998"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2026-01-13T23:59:59+00:00"
generated_at: "2026-05-16T10:42:25.307289+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma receives Nasdaq deficiency notice for failure to hold annual meeting

## Summary
- Received Nasdaq letter on Jan 7, 2026, citing non-compliance with Listing Rule 5620(a) for not holding annual meeting.
- Company has 45 calendar days to submit a plan to regain compliance.
- Expects to convene annual meeting in April 2026 and will consult with Nasdaq on compliance.
- No immediate impact on listing or trading of ESLA common stock or ESLAW warrants.

## SEC filing metadata
- accession: 0001213900-26-003998
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2026-01-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390026003998/0001213900-26-003998-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390026003998/ea027282201-8k_estrellaimmu.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-003998
- JSON: https://secwatch.observer/filing/0001213900-26-003998.json
- Plain text: https://secwatch.observer/filing/0001213900-26-003998.txt

## Source-grounded claims
- claim_id: 857f358541e1f3dcd347ae68aafb4424c4c0dd61
  claim: Estrella Immunopharma, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).
  evidence_excerpt: January 7, 2026, Estrella Immunopharma, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5620(a) because the Company has not held an annual meeting of shareholders within the required time period. The Letter also referenced the compliance plan procedures under Nasdaq Listing Rule 5810(c)(2)(G). The Letter states that the Company has 45 calendar days to submit a plan to regain compliance. The Company intends to submit its compliance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844417/000121390026003998/0001213900-26-003998-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.